Four-year overall survival update from the phase 3 HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma Meeting Abstract
| Authors: | Sangro, B.; Chan, S.; Kelley, R.; Lau, G.; Kudo, M.; Sukeepaisarnjaroen, W.; De Toni, E.; Furuse, J.; Kang, Y.; Galle, P.; Rimassa, L.; Heurgué, A.; Tam, V.; Dao, T.; Thungappa, S.; Breder, V.; Ostapenko, Y.; Reig, M.; Makowsky, M.; Gupta, C.; Negro, A.; Abou-Alfa, G. |
| Abstract Title: | Four-year overall survival update from the phase 3 HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma |
| Meeting Title: | 25th World Congress on Gastrointestinal Cancer (ESMO 2023) |
| Keywords: | oncology |
| Journal Title: | Annals of Oncology |
| Volume: | 34 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Jun 28-Jul 1 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-06-01 |
| Start Page: | S168 |
| Language: | English |
| ACCESSION: | WOS:001037960400439 |
| DOI: | 10.1016/j.annonc.2023.04.487 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: SO-15 -- Source: Wos |
